A detailed history of Signaturefd, LLC transactions in Nkarta, Inc. stock. As of the latest transaction made, Signaturefd, LLC holds 573 shares of NKTX stock, worth $1,432. This represents 0.0% of its overall portfolio holdings.

Number of Shares
573
Previous 228 151.32%
Holding current value
$1,432
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$4.52 - $8.0 $1,559 - $2,760
345 Added 151.32%
573 $2,000
Q2 2024

Jul 29, 2024

BUY
$5.27 - $10.82 $953 - $1,958
181 Added 385.11%
228 $1,000
Q1 2024

May 03, 2024

BUY
$5.59 - $15.71 $262 - $738
47 New
47 $0
Q4 2022

Jan 27, 2023

SELL
$5.14 - $14.35 $1,346 - $3,759
-262 Reduced 80.12%
65 $0
Q2 2022

Aug 10, 2022

BUY
$7.77 - $19.44 $644 - $1,613
83 Added 34.02%
327 $4,000
Q1 2022

May 02, 2022

SELL
$8.66 - $14.99 $623 - $1,079
-72 Reduced 22.78%
244 $3,000
Q4 2021

Jan 25, 2022

BUY
$12.79 - $26.88 $3,593 - $7,553
281 Added 802.86%
316 $5,000
Q3 2021

Oct 28, 2021

BUY
$26.67 - $38.76 $933 - $1,356
35 New
35 $1,000

Others Institutions Holding NKTX

About Nkarta, Inc.


  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $122M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track This Portfolio

Track Signaturefd, LLC Portfolio

Follow Signaturefd, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.